Model Checkpoint Epoch: 5.0
Evaluation Model Used: gpt-5-mini
Number of Prompts Printed: 5
Number of Prompts Used for Calculating the Average for Each Metric: 20
QLoRA Adapter Configuration:
	Rank: 64
	QLoRA Alpha: 64.0 

================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Undernutrition in neonates increases the risk of serious morbidities. The objective of this study was to describe neonatal morbidity associated with low body fat percentage (BF%) and measure the number of undernourished neonates defined by BF% and compare this with birth weight percentiles (<10th). Eligibility included term (≥37 wk) neonates. BF% measurements were undertaken by air displacement plethysmography. Data on neonatal outcomes were extracted from medical records and used to develop a measure of neonatal morbidity. We assessed the association between neonatal morbidity and population-based birth weight percentiles compared with the BF% measurements. Five hundred and eighty-one neonates were included. Low BF% was defined by 1 SD below the mean and identified in 73 per 1,000 live births. Neonatal morbidity was found in 3.4% of neonates. Birth weight percentile was associated with neonatal morbidity (odds ratio (OR): 1.03 (95% confidence interval (CI): 1.01, 1.05); P =<0.001). BF% was associated with a higher risk of neonatal morbidity (OR: 1.30 (95% CI: 1.15, 1.47); P =<0.001).
Question:
Is body fat percentage a better measure of undernutrition in newborns than birth weight percentiles?
[/INST]

Generated Answer: Our results suggest that BF% is an excellent marker of undernutrition in neonates. It provides a more accurate estimate of nutritional status than birth weight percentiles. This may be because BF% reflects both the amount of fat and lean tissue present in the body and can provide a more comprehensive assessment of energy availability. In contrast, birth weight alone does not take into account body composition or fat free mass. Our findings support the use of BF% as a valid indicator of undernutrition in neonates and highlight the importance of considering BF% in addition to birth weight when assessing nutritional status in this vulnerable population. Further studies are required to confirm our findings and establish whether BF% should replace birth weight percentiles as the primary measure of undernutrition in neonates. However, our findings suggest that it is important to consider BF% in addition to birth weight when assessing undernutrition in this population.

Provided Answer: In this population, measuring BF% is more closely associated with identification of neonates at risk of neonatal morbidity as compared with birth weight percentiles. BF% measurements could assist with identifying neonates who are appropriately grown yet undernourished and exclude small neonates not at risk. 

correctness: 0.9
Reasoning:
The assistant's answer correctly concludes that body fat percentage (BF%) is a better indicator than birth weight percentiles for identifying neonates at risk of morbidity based on the study findings. It appropriately cites the greater relevance of body composition versus weight alone and reasonably recommends considering BF% alongside birth weight while calling for further study. Minor overstatements (e.g., calling BF% "excellent") and a small imprecision about BF% "reflecting both the amount of fat and lean tissue" (BF% quantifies fat proportion relative to fat‑free mass rather than directly measuring absolute lean mass) prevent a perfect score.

conciseness: 0.6
Reasoning:
The assistant directly answers “yes” and gives a brief rationale, so the response is relevant; however it is somewhat wordy and repetitive (repeats the conclusion and the recommendation to consider BF%), and includes extra hedging that could be shorter. Overall it could be tightened to one or two clear sentences citing the study result. 


relevance: 0.4
Reasoning:
The response answers the question directly and concludes that BF% is a better measure than birth weight percentiles, which is relevant to the context. However it does not quote or cite any specific line or numeric result from the provided context (e.g., the reported ORs or the statement that BF% identified 73 per 1,000 live births and was more closely associated with morbidity), and it adds explanatory claims about lean tissue that are not explicitly supported by the quoted study text. Because the prompt required referring to a real quote from the context, the response is only partially compliant.

coherence: 0.9
Reasoning:
The response is coherent and well organized: it directly answers the question, summarizes the study finding that BF% is a better indicator than birth weight percentiles, gives a plausible rationale (BF% reflects body composition), and appropriately notes the need for further study. It could be improved by citing specific results (e.g., odds ratios or prevalence) and avoiding slight overstatements (calling BF% "excellent" without numbers), but overall it stays focused and clear.

helpfulness: 0.7
Reasoning:
The assistant's reply correctly answers the question by stating that BF% better identifies undernutrition than birth weight percentiles and gives a plausible reason (BF% reflects body composition rather than just mass). It also appropriately cautions that further study is needed. However, the response is somewhat overconfident (“excellent marker”) and lacks supporting detail from the study (no mention of the reported odds ratios, prevalence, BF% cutoff, sample size, or practical limitations such as the need for air displacement plethysmography). It also omits the useful nuance that birth weight percentiles were still associated with morbidity but less strongly, and that BF% can identify neonates who are appropriately grown yet undernourished. Overall the answer is helpful and directionally correct but incomplete and a bit overstated.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
We retrospectively collected and analyzed data of all diabetic patients affected by Charcot neuroarthropathy in combination with critical limb ischemia, which arrived to our care for the presence of foot lesions and underwent endovascular revascularization, followed by surgical and orthopedic treatment between January 2010 and January 2012. The primary end point was to assess the limb salvage rate. The secondary end point was to evaluate the healing time of the lesions. Ten diabetic patients (10 men; mean age 69.1±8.5 years), affected by ischemic Charcot neuroarthropathy underwent endovascular revascularization, surgical debridement and orthopedic correction. The limb salvage rate was 90%, avoiding major amputation in 9 patients. In one patient (10%) the infection could not be controlled and below-the-knee amputation was carried out. The required time to heal the lesion was in mean 197.4±22.4 days, after revascularization, surgical and orthopedic treatment.
Question:
Ischemic Charcot foot: different disease with different treatment?
[/INST]

Generated Answer: The clinical presentation and management of Charcot arthropathy of the foot is highly heterogeneous. Different treatments have been proposed for this condition, but the results of these interventions may differ according to the underlying pathophysiology. Therefore, we can consider the diagnosis of ischemic Charcot neuroarthropathy as a separate entity from nonischemic Charcot neuroarthropathy. However, the pathogenesis of both entities remains unclear. We suggest that ischemic Charcot neuroarthropathy is a distinct form of Charcot neuroarthropathy, which requires a specific approach to its prevention and treatment. This hypothesis has been supported by several authors, who have demonstrated a higher prevalence of peripheral vascular disease in patients affected by ischemic Charcot neuroarthropathy than in those affected by nonischemic Charcot neuroarthropathy. Moreover, it has also been observed that ischemic Charcot neuroarthropathy is more frequently associated with ulceration or gangrene of the plantar surface of the foot. This could be due to the poor perfusion of the foot in these patients. Therefore, we recommend considering the diagnosis of ischemic Charcot neuroarthropathy in any patient presenting with severe foot pain and ulceration. In such cases, we should consider the possibility of peripheral vascular disease, especially if there is no evidence of neuropathy. We must also remember that even in patients with typical neuropathic changes, there may be a significant component of peripheral vascular disease, and the two conditions may coexist in the same patient. In summary, the definition of ischemic Charcot neuroarthropathy is based on the presence of neurologic symptoms and signs caused by denervation, with the absence of neuropathy. These patients require careful evaluation and treatment. If the underlying peripheral vascular disease is corrected, the outcome will improve. In contrast, if the peripheral vascular disease persists, the outcome may remain poor despite the correction of neurologic symptoms and signs. Therefore, the prevention and treatment of peripheral vascular disease should always be considered when treating patients with Charcot neuroarthropathy.

Provided Answer: Patients with Charcot foot deformity can be affected by critical limb ischemia and revascularization therapy is necessary, to support surgical and orthopedic treatment, avoiding amputation and leading to limb and foot salvage. 

correctness: 0.3
Reasoning:
The assistant's reply includes some correct points (Charcot foot is heterogeneous; peripheral vascular disease can coexist and increase ulceration risk) but it fails to address the key clinical conclusion shown in the ground truth — that ischemic Charcot feet with critical limb ischemia often require revascularization to enable surgical/orthopedic treatment and achieve high limb-salvage rates. The answer also contains clear errors and contradictions (e.g., defining ischemic Charcot neuroarthropathy as having neurologic signs "with the absence of neuropathy") and remains vague about management recommendations. Overall it is misleading and incomplete.

conciseness: 0.3
Reasoning:
The response is verbose and repetitive and does not concisely answer the question. While it conveys the useful point that ischemic Charcot neuroarthropathy should be considered a distinct presentation that requires evaluation and management of peripheral vascular disease (including revascularization to support limb salvage), it includes self-contradictory and confusing statements (for example, claiming both "neurologic symptoms... caused by denervation" and "absence of neuropathy"), and it fails to give a clear, direct conclusion or practical treatment recommendation. Overall it answers the question but not succinctly or precisely.

relevance: 0.3
Reasoning:
The answer addresses the question by asserting that ischemic Charcot neuroarthropathy is a distinct entity requiring a different treatment approach, but it fails to refer to or quote the provided study data (no mention of revascularization, limb-salvage rate, or healing time). It also contains at least one self-contradictory statement about neuropathy/denervation, reducing clarity and reliability. Overall it answers the question in principle but does not ground that answer in the context given and includes inaccuracies.

coherence: 0.3
Reasoning:
The response is poorly coherent and contains factual and logical inconsistencies. It is repetitive, makes unsupported generalizations, and contradicts itself (for example, saying the diagnosis is "based on the presence of neurologic symptoms and signs caused by denervation, with the absence of neuropathy"). It also fails to clearly address the practical treatment implication shown in the ground truth — namely that ischemic Charcot feet often require revascularization to enable surgical/orthopedic treatment and improve limb salvage — and instead gives vague recommendations without citing the key management step. Overall the answer is disorganized and potentially misleading.

helpfulness: 0.2
Reasoning:
Explanation: The response attempts to distinguish "ischemic Charcot" as a separate entity and to emphasize the role of peripheral vascular disease, but it is vague, contains contradictory and inaccurate statements (for example saying the definition is "neurologic symptoms... with the absence of neuropathy"), and fails to address the clinical implication shown in the ground-truth data — namely that critical limb ischemia complicating Charcot foot often requires revascularization (endovascular or surgical) to enable surgical/orthopedic treatment and improve limb salvage. It gives unsubstantiated generalities about prevalence and outcomes instead of citing or using the presented study results (90% limb salvage after revascularization and mean healing time ~197 days). Overall the reply is not sufficiently accurate, specific, or evidence-based to be helpful for the question asked.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
Radical hysterectomy is recommended for endometrial adenocarcinoma patients with suspected gross cervical involvement. However, the efficacy of operative procedure has not been confirmed. The patients with endometrial adenocarcinoma who had suspected gross cervical involvement and underwent hysterectomy between 1995 and 2009 at seven institutions were retrospectively analysed (Gynecologic Oncology Trial and Investigation Consortium of North Kanto: GOTIC-005). Primary endpoint was overall survival, and secondary endpoints were progression-free survival and adverse effects. A total of 300 patients who underwent primary surgery were identified: 74 cases with radical hysterectomy (RH), 112 patients with modified radical hysterectomy (mRH), and 114 cases with simple hysterectomy (SH). Median age was 47 years, and median duration of follow-up was 47 months. There were no significant differences of age, performance status, body mass index, stage distribution, and adjuvant therapy among three groups. Multi-regression analysis revealed that age, grade, peritoneal cytology status, and lymph node involvement were identified as prognostic factors for OS; however, type of hysterectomy was not selected as independent prognostic factor for local recurrence-free survival, PFS, and OS. Additionally, patients treated with RH had longer operative time, higher rates of blood transfusion and severe urinary tract dysfunction.
Question:
Surgery for endometrial cancers with suspected cervical involvement: is radical hysterectomy needed (a GOTIC study)?
[/INST]

Generated Answer: Although the effectiveness of operative procedure for endometrial cancer with suspected cervical involvement remains to be confirmed, this study suggests that in some cases, RH may be necessary for improved survival outcomes. Prospective studies should be considered to determine the role of RH in the management of endometrial cancer with suspected cervical involvement. Further data on the influence of adjuvant therapy and patient selection would be important to confirm these findings. However, the risk of severe urinary tract dysfunction after RH should be taken into consideration when making treatment decisions. We recommend discussing with the attending physician to determine the best course of action based on individual patient conditions. This study provides valuable information about the prognostic significance of different surgical procedures. Further studies should investigate the optimal treatment strategy for patients with endometrial cancer and suspected cervical involvement. Patients should receive appropriate care, including hormonal therapy, chemotherapy, or radiation therapy, if indicated. Radical hysterectomy appears to be associated with a greater risk of complications compared to other procedures. It is important to consider the benefits and risks of each procedure before making a decision. A careful evaluation of the patient's condition will help guide the choice of treatment. It is also essential to discuss the possibility of future infertility and sexual function after surgery. Patients with endometrial cancer should be informed about the potential risks and benefits of each treatment option. Patients should be encouraged to ask their healthcare providers any questions they have regarding their treatment options and to discuss their concerns openly and honestly. In summary, while more investigation is required to establish the role of RH in the management of endometrial cancer with suspected cervical involvement, it is clear that further research is warranted to optimize patient outcomes. This study highlights the need for further clinical trials to identify the most effective management strategy for this disease. It is important to develop and implement evidence-based guidelines to improve patient care. Further research is required to evaluate the impact of RH on recurrence rates, survival outcomes, and long-term quality of life in patients with endometrial cancer.

Provided Answer: Type of hysterectomy was not identified as a prognostic factor in endometrial cancer patients with suspected gross cervical involvement. Perioperative and late adverse events were more frequent in patients treated with RH. The present study could not find any survival benefit from RH for endometrial cancer patients with suspected gross cervical involvement. Surgical treatment in these patients should be further evaluated in prospective clinical studies. 

correctness: 0.3
Reasoning:
The assistant's reply is misleading and partly incorrect. The core claim that "RH may be necessary for improved survival outcomes" contradicts the GOTIC-005 study results, which found that type of hysterectomy was not an independent prognostic factor and that no survival benefit from radical hysterectomy (RH) was demonstrated. Correct points in the reply include noting higher rates of perioperative complications (including severe urinary tract dysfunction) with RH and the reasonable recommendation for prospective studies and individualized patient counseling. The response also includes some extraneous or unsupported suggestions (e.g., blanket mentions of hormonal therapy) and repeats general advice rather than accurately summarizing the study's primary conclusions.

conciseness: 0.2
Reasoning:
The response is verbose and repetitive, failing the conciseness criterion. It does not succinctly summarize the study’s main findings and incorrectly asserts that radical hysterectomy (RH) "may be necessary for improved survival outcomes" despite the study finding no survival benefit of RH and identifying hysterectomy type as not an independent prognostic factor. It also repeats generic recommendations and patient counseling points rather than clearly stating the key results (no survival benefit from RH; higher perioperative/late adverse events with RH; need for prospective studies).

relevance: 0.2
Reasoning:
The assistant's reply is largely irrelevant to the study context because it asserts that radical hysterectomy (RH) "may be necessary for improved survival outcomes," whereas the provided study explicitly found no survival benefit and that type of hysterectomy was not an independent prognostic factor. The reply correctly mentions increased complications (urinary dysfunction) with RH, but it fails to cite or accurately reflect the study's primary conclusions and adds several unsupported general recommendations (e.g., hormonal therapy) not drawn from the context.

coherence: 0.3
Reasoning:
The assistant's answer is poorly coherent relative to the study's actual findings. It repeatedly gives generic, non-specific recommendations, and contradicts the core result by implying RH "may be necessary for improved survival outcomes" despite the study showing no survival benefit and identifying hysterectomy type as not an independent prognostic factor. A few points (noting higher urinary tract dysfunction with RH; calling for prospective studies) align with the study, but the response otherwise fails to accurately or succinctly summarize the primary and secondary endpoints, omits key data, and is repetitive.

helpfulness: 0.3
Reasoning:
Explanation: The assistant's reply is partly helpful (it notes higher complication rates with radical hysterectomy and calls for prospective study and individualized decision-making), but it misrepresents the primary results of the GOTIC study and omits key findings. Specifically, the study found that hysterectomy type was not an independent prognostic factor and that radical hysterectomy did not provide a survival benefit; instead the assistant asserts that RH "may be necessary for improved survival outcomes," which contradicts the study data. The answer is also repetitive and adds generic counseling points that, while reasonable, do not substitute for accurately summarizing the study's conclusions.

================================================================================
================================================================================
Prompt: [INST] <<SYS>>
You are a helpful AI assistant that answers biomedical research questions concisely.
<</SYS>>
Context:
The morbidity and mortality of pancreaticoduodenectomy (PD) have significantly decreased over the past decades to the point that they are no longer the sole indicators of quality and safety. In recent times, hospital readmission is increasingly used as a quality metric for surgical performance and has direct implications on health-care costs. We sought to delineate the natural history and predictive factors of readmissions after PD. The clinicopathologic and long-term follow-up data of 1,173 consecutive patients who underwent PD between August 2002 and August 2012 at the Massachusetts General Hospital were reviewed. The NSQIP database was linked with our clinical database to supplement perioperative data. Readmissions unrelated to the index admission were omitted. We identified 173 (15 %) patients who required readmission after PD within the study period. The readmission rate was higher in the second half of the decade when compared to the first half (18.6 vs 12.3 %, p = 0.003), despite a stable 7-day median length of stay. Readmitted patients were analyzed against those without readmissions after PD. The demographics and tumor pathology of both groups did not differ significantly. In the multivariate logistic regression analysis, pancreatic fistula (18.5 vs 11.3 %, OR 1.86, p = 0.004), multivisceral resection at time of PD (3.5 vs 0.6 %, OR 4.02, p = 0.02), length of initial hospital stay>7 days (59.5 vs 42.5 %, OR 1.57, p = 0.01), and ICU admissions (11.6 vs 3.4 %, OR 2.90, p = 0.0005) were independently associated with readmissions. There were no postoperative biochemical variables that were predictive of readmissions. Fifty percent (n = 87) of the readmissions occurred within 7 days from initial operative discharge. The reasons for immediate (≤7 days) and nonimmediate (>7 days) readmissions differed; ileus, delayed gastric emptying, and pneumonia were more common in early readmissions, whereas wound infection, failure to thrive, and intra-abdominal hemorrhage were associated with late readmissions. The incidences of readmissions due to pancreatic fistulas and intra-abdominal abscesses were equally distributed between both time frames. The frequency of readmission after PD is 15 % and has been on the uptrend over the last decade.
Question:
Understanding hospital readmissions after pancreaticoduodenectomy: can we prevent them?
[/INST]

Generated Answer: Readmissions after PD can be minimized by several strategies. Future studies should focus on identifying risk factors and implementing interventions aimed at reducing their incidence. Improved communication between physicians and nurses during patient transfer may reduce the risk of readmission. The use of standardized protocols for bowel preparation, anesthesia, and antibiotic prophylaxis could also help reduce readmissions. Further studies are needed to determine whether enhanced recovery programs improve outcomes after PD. The need for an urgent readmission indicates that further investigation is warranted to identify potential causes. Prevention of delayed gastric emptying and pancreatic fistulas, which are known to increase the risk of readmissions, should be considered. Finally, improved patient education regarding expectations after PD may help reduce anxiety and promote self-care, thereby reducing the need for readmission. To conclude, prevention of readmissions after PD requires a multifactorial approach that includes risk factor assessment and modification, improved communication, standardization of care protocols, and further evaluation of the role of enhanced recovery programs. By optimizing these strategies, the incidence of readmissions after PD can be significantly reduced.

Provided Answer: The complexity of initial resection and pancreatic fistula were independently associated with hospital readmissions after PD. Further efforts should be centered on preventing early readmissions, which constitute half of all readmissions. 

correctness: 0.4
Reasoning:
The assistant's answer is generic and only partly aligned with the ground truth. It correctly mentions pancreatic fistula as a target for prevention and recommends a multifactorial approach, but it omits the key finding that complexity of the initial resection (e.g., multivisceral/complex resections) was independently associated with readmission. It also fails to emphasize that half of readmissions occur early (≤7 days) and that efforts should particularly target preventing these early readmissions. Some recommended interventions are vague or not clearly tied to the study findings.

conciseness: 0.4
Reasoning:
The response is wordy and fairly general rather than concise. It repeats recommendations (e.g., future studies, standardized protocols, improved communication) and does not clearly prioritize or highlight the study’s key, specific findings (complex initial resection and pancreatic fistula as independent predictors, and that half of readmissions occur within 7 days). Overall it answers the question at a high level but is not tightly focused or succinct.

relevance: 0.5
Reasoning:
The assistant's reply partly answers the question and references real findings from the context (it correctly highlights pancreatic fistula and delayed gastric emptying as contributors to readmission). However, it omits key context results (the independent association of more complex initial resections/multivisceral resection with readmissions and the fact that about half of readmissions are early ≤7 days and thus merit targeted prevention). It also adds many general recommendations (bowel prep, anesthesia, antibiotic protocols) that are not supported by the provided study text. Overall, relevant in part but incomplete and not fully grounded in the cited findings.

coherence: 0.4
Reasoning:
The reply is coherent and well-structured, offering several plausible, general strategies to reduce readmissions after PD (risk-factor assessment, care-standardization, communication, patient education). However it is fairly generic and misses several key, study-specific findings that should have been addressed: it only briefly mentions pancreatic fistula but omits that complexity of the initial resection (multivisceral resection), prolonged initial length of stay, and ICU admission were independently associated with readmission; it fails to note that ~50% of readmissions occur early (≤7 days) and that prevention efforts should prioritize early readmissions. Some proposed measures (eg, routine bowel preparation or generic antibiotic protocols) are not clearly supported by the presented data. Overall, coherent but incomplete and only partially aligned with the ground-truth findings.

helpfulness: 0.5
Reasoning:
The response offers broadly reasonable, general strategies (multifactorial prevention, patient education, attention to pancreatic fistula and delayed gastric emptying, consideration of enhanced recovery), so it is somewhat helpful. However it is generic, not well grounded in the study’s specific findings: it omits the independent association of complex/multivisceral resections with readmission and fails to emphasize that half of readmissions occur within 7 days (so preventing early readmissions should be prioritized). It also suggests some measures of questionable relevance (routine bowel preparation) and lacks concrete, evidence‑linked recommendations or prioritization based on the reported data.

================================================================================
Average correctness Score: 0.56
Average conciseness Score: 0.515
Average relevance Score: 0.54
Average coherence Score: 0.635
Average helpfulness Score: 0.52
